INDEGENE
|
The Current P/E Ratio of INDEGENE is 34.45.
Share Price | ₹551.1 | Apr 08,2025 |
Market Cap | ₹13,226.4 Cr | |
Earnings-TTM | ₹383.9 Cr | TTM-Consolidated Results |
Price/Earnings | 34.45x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of INDEGENE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹13,226.4 Cr] as on Apr 08,2025
(/) Earnings [ ₹383.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 34.45x ]
Thus, for INDEGENE , the investors are currently willing to pay 34.45 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INDEGENE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INDEGENE over the last five years.
Historical PE (Price/Earnings) ratio chart of INDEGENE
PE Ratio Performance Analysis for INDEGENE
- INDEGENE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.
- INDEGENE 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDEGENE 's p/e ratio peaked in Mar2024 at 0x.
- INDEGENE 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does INDEGENE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
INDEGENE | 383.90 | 34.45 | 13,226.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.28 | 405,188.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 69.22 | 143,074.0 |
CIPLA LTD | 5,000.43 | 23.15 | 115,768.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 58.97 | 109,809.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.04 | 92,503.5 |
MANKIND PHARMA LTD | 2,050.73 | 47.15 | 96,689.8 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 18.84 | 86,490.8 |
LUPIN LTD | 2,892.10 | 31.30 | 90,520.9 |
AUROBINDO PHARMA LTD | 3,500.25 | 18.20 | 63,702.3 |
ABBOTT INDIA LTD | 1,334.46 | 46.84 | 62,501.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INDEGENE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.04x |
Max industry PE | 69.22x |
Median industry PE | 34.45x |
Average industry PE | 36.40x |
You may also like the below Video Courses